Wiebe C et al. |
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28729289
|
Kita K and Mano Y |
Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition. |
2017 |
J Pharm Biomed Anal |
pmid:28601765
|
Abongwa C et al. |
Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient. |
2017 |
Pediatr Blood Cancer |
pmid:28598573
|
Wu Z et al. |
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients. |
2017 |
Eur. J. Clin. Pharmacol. |
pmid:27747372
|
Sharma N et al. |
Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. |
2017 |
J. Rheumatol. |
pmid:28864644
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Henderson CN et al. |
Continuous Abdominal Irrigation for Treatment of Tertiary Peritonitis in the Immunosuppressed Patient after Solid Organ Transplant: A Novel Approach. |
2017 |
Am Surg |
pmid:28424115
|
Zhang L et al. |
Characterization of calcineurin from Cryptococcus humicola and the application of calcineurin in aluminum tolerance. |
2017 |
BMC Biotechnol. |
pmid:28356086
|
Marini BL et al. |
Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant. |
2017 |
J Oncol Pharm Pract |
pmid:26970572
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Cui W et al. |
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. |
2017 |
Braz. J. Med. Biol. Res. |
pmid:28355356
|
Vanhove T et al. |
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28168728
|
Dong Y et al. |
Risk Factors, Clinical Features, and Treatment Outcomes of Recurrent Mooren Ulcers in China. |
2017 |
Cornea |
pmid:28060068
|
de Oliveira JTP et al. |
Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12Â years: Non-adherence or risk of non-adherence? |
2017 |
Pediatr Transplant |
pmid:29034612
|
Kim YK et al. |
New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients. |
2017 |
Drug Des Devel Ther |
pmid:29033547
|
Dutta D et al. |
Recruitment of calcineurin to the TCR positively regulates T cell activation. |
2017 |
Nat. Immunol. |
pmid:27941787
|
Perez LE et al. |
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. |
2017 |
Bone Marrow Transplant. |
pmid:27991896
|
Naicker D et al. |
Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28660366
|
Sigurgeirsson B and Luger T |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response. |
2017 |
Br. J. Dermatol. |
pmid:28940181
|
Qi H et al. |
Integration of parallel C-labeling experiments and in silico pathway analysis for enhanced production of ascomycin. |
2017 |
Biotechnol. Bioeng. |
pmid:27869289
|